These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21978999)

  • 1. Efficacy of intravenous Ig therapy in juvenile dermatomyositis.
    Lam CG; Manlhiot C; Pullenayegum EM; Feldman BM
    Ann Rheum Dis; 2011 Dec; 70(12):2089-94. PubMed ID: 21978999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin therapy for juvenile dermatomyositis: efficacy and safety.
    Al-Mayouf SM; Laxer RM; Schneider R; Silverman ED; Feldman BM
    J Rheumatol; 2000 Oct; 27(10):2498-503. PubMed ID: 11036850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients.
    Cherin P; Piette JC; Wechsler B; Bletry O; Ziza JM; Laraki R; Godeau P; Herson S
    J Rheumatol; 1994 Jun; 21(6):1092-7. PubMed ID: 7932419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intravenously-administered immunoglobulins as first-choice agent in juvenile dermatomyositis].
    Breems DA; de Haas PW; Visscher F; Sabbe LJ; Busch HF; van Doorn PA
    Ned Tijdschr Geneeskd; 1993 Sep; 137(39):1979-82. PubMed ID: 8413708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
    Furukawa T; Kishiro M; Akimoto K; Nagata S; Shimizu T; Yamashiro Y
    Arch Dis Child; 2008 Feb; 93(2):142-6. PubMed ID: 17962370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin in the treatment of polyarticular juvenile rheumatoid arthritis: a phase I/II study. Pediatric Rheumatology Collaborative Study Group.
    Giannini EH; Lovell DJ; Silverman ED; Sundel RP; Tague BL; Ruperto N
    J Rheumatol; 1996 May; 23(5):919-24. PubMed ID: 8724309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients.
    Marie I; Menard JF; Hatron PY; Hachulla E; Mouthon L; Tiev K; Ducrotte P; Cherin P
    Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1748-55. PubMed ID: 20722047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mineral apparent density in juvenile dermatomyositis: the role of lean body mass and glucocorticoid use.
    Santiago RA; Silva CA; Caparbo VF; Sallum AM; Pereira RM
    Scand J Rheumatol; 2008; 37(1):40-7. PubMed ID: 18189194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin therapy in juvenile dermatomyositis.
    Tsai MJ; Lai CC; Lin SC; Chiang BL; Chou CC; Hsieh KH
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1997; 38(2):111-5. PubMed ID: 9151463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments.
    Basta M; Dalakas MC
    J Clin Invest; 1994 Nov; 94(5):1729-35. PubMed ID: 7962520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin therapy in systemic onset juvenile rheumatoid arthritis: a followup study.
    Uziel Y; Laxer RM; Schneider R; Silverman ED
    J Rheumatol; 1996 May; 23(5):910-8. PubMed ID: 8724308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of high-dose immune globulin intravenous in the treatment of dermatomyositis.
    Dalakas MC
    Int Immunopharmacol; 2006 Apr; 6(4):550-6. PubMed ID: 16504918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intravenous cyclophosphamide pulse therapy for refractory juvenile dermatomyositis].
    Nakashima S; Mori M; Miyamae T; Ito S; Ibe M; Aihara Y; Yokota S
    Ryumachi; 2002 Dec; 42(6):895-902. PubMed ID: 12632609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunoglobulins or plasma exchange? New treatment methods in polymyositis and dermatomyositis: plasma exchange and intravenous immunoglobulins].
    Chérin P; Herson S
    Ann Med Interne (Paris); 1993; 144(8):521-5. PubMed ID: 8179241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
    Yang Y; Xu J; Li F; Zhu X
    Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favorable outcome of juvenile dermatomyositis treated without systemic corticosteroids.
    Levy DM; Bingham CA; Kahn PJ; Eichenfield AH; Imundo LF
    J Pediatr; 2010 Feb; 156(2):302-7. PubMed ID: 19846111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin therapy for patients with bullous pemphigoid unresponsive to conventional immunosuppressive treatment.
    Ahmed AR
    J Am Acad Dermatol; 2001 Dec; 45(6):825-35. PubMed ID: 11712025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multifocal motor neuropathy: a retrospective study of the response to high-dose intravenous immunoglobulin (IVIg) and current perspectives for diagnosis and treatment].
    Léger JM; Viala K; Maisonobe T; Bouche P
    Bull Acad Natl Med; 2007 Oct; 191(7):1395-407; discussion 1407-9. PubMed ID: 18447061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medications received by patients with juvenile dermatomyositis.
    Kishi T; Bayat N; Ward MM; Huber AM; Wu L; Mamyrova G; Targoff IN; Warren-Hicks WJ; Miller FW; Rider LG;
    Semin Arthritis Rheum; 2018 Dec; 48(3):513-522. PubMed ID: 29773230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IV immunoglobulin is associated with a reduced risk of Alzheimer disease and related disorders.
    Fillit H; Hess G; Hill J; Bonnet P; Toso C
    Neurology; 2009 Jul; 73(3):180-5. PubMed ID: 19620605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.